0001209191-22-022263.txt : 20220404 0001209191-22-022263.hdr.sgml : 20220404 20220404150736 ACCESSION NUMBER: 0001209191-22-022263 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220404 DATE AS OF CHANGE: 20220404 EFFECTIVENESS DATE: 20220404 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lung Therapeutics, Inc. CENTRAL INDEX KEY: 0001611241 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461383209 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-440261 FILM NUMBER: 22801668 BUSINESS ADDRESS: STREET 1: P.O. BOX 150183 CITY: AUSTIN STATE: TX ZIP: 78715 BUSINESS PHONE: 512-809-8549 MAIL ADDRESS: STREET 1: P.O. BOX 150183 CITY: AUSTIN STATE: TX ZIP: 78715 D 1 primary_doc.xml X0708 D LIVE 0001611241 Lung Therapeutics, Inc. 3801 S. Capital of TX Hwy Suite 330 Austin TX TEXAS 78704 737-802-1989 TEXAS None None Corporation true Brian Windsor 3801 S. Capital of TX Hwy Suite 330 Austin TX TEXAS 78704 Executive Officer Director Aaron G.L. Fletcher 3801 S. Capital of TX Hwy Suite 330 Austin TX TEXAS 78704 Director William C. Fairey 3801 S. Capital of TX Hwy Suite 330 Austin TX TEXAS 78704 Director Charles Garner 3801 S. Capital of TX Hwy Suite 330 Austin TX TEXAS 78704 Executive Officer Biotechnology Decline to Disclose 06b false 2022-03-14 false true true false 15000 Newbridge Securities Corporation 104065 None None 1200 North Federal Highway, Suite 400 Boca Raton FL FLORIDA 33432 AL ALABAMA AZ ARIZONA AR ARKANSAS CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE DC DISTRICT OF COLUMBIA FL FLORIDA GA GEORGIA IL ILLINOIS IN INDIANA IA IOWA MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MO MISSOURI NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OH OHIO OK OKLAHOMA PA PENNSYLVANIA SC SOUTH CAROLINA TX TEXAS UT UTAH VA VIRGINIA WA WASHINGTON WI WISCONSIN 15000000 10065000 4935000 false 213 0 855525 0 false Lung Therapeutics, Inc. /s/ Charles Garner Charles Garner Chief Financial Officer 2022-04-04